Literature DB >> 26324937

NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability.

Sarah Croessmann1, Hong Yuen Wong1, Daniel J Zabransky1, David Chu1, Janet Mendonca1, Anup Sharma1, Morassa Mohseni1, D Marc Rosen1, Robert B Scharpf1, Justin Cidado1, Rory L Cochran1, Heather A Parsons1, W Brian Dalton1, Bracha Erlanger1, Berry Button1, Karen Cravero1, Kelly Kyker-Snowman1, Julia A Beaver1, Sushant Kachhap1, Paula J Hurley1, Josh Lauring1, Ben Ho Park2.   

Abstract

The tumor protein 53 (TP53) tumor suppressor gene is the most frequently somatically altered gene in human cancers. Here we show expression of N-Myc down-regulated gene 1 (NDRG1) is induced by p53 during physiologic low proliferative states, and mediates centrosome homeostasis, thus maintaining genome stability. When placed in physiologic low-proliferating conditions, human TP53 null cells fail to increase expression of NDRG1 compared with isogenic wild-type controls and TP53 R248W knockin cells. Overexpression and RNA interference studies demonstrate that NDRG1 regulates centrosome number and amplification. Mechanistically, NDRG1 physically associates with γ-tubulin, a key component of the centrosome, with reduced association in p53 null cells. Strikingly, TP53 homozygous loss was mutually exclusive of NDRG1 overexpression in over 96% of human cancers, supporting the broad applicability of these results. Our study elucidates a mechanism of how TP53 loss leads to abnormal centrosome numbers and genomic instability mediated by NDRG1.

Entities:  

Keywords:  NDRG1; centrosomes; genomic instability; p53; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26324937      PMCID: PMC4577188          DOI: 10.1073/pnas.1503683112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.

Authors:  Jianjiong Gao; Bülent Arman Aksoy; Ugur Dogrusoz; Gideon Dresdner; Benjamin Gross; S Onur Sumer; Yichao Sun; Anders Jacobsen; Rileen Sinha; Erik Larsson; Ethan Cerami; Chris Sander; Nikolaus Schultz
Journal:  Sci Signal       Date:  2013-04-02       Impact factor: 8.192

3.  Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.

Authors:  Hiroyuki Konishi; Morassa Mohseni; Akina Tamaki; Joseph P Garay; Sarah Croessmann; Sivasundaram Karnan; Akinobu Ota; Hong Yuen Wong; Yuko Konishi; Bedri Karakas; Khola Tahir; Abde M Abukhdeir; John P Gustin; Justin Cidado; Grace M Wang; David Cosgrove; Rory Cochran; Danijela Jelovac; Michaela J Higgins; Sabrina Arena; Lauren Hawkins; Josh Lauring; Amy L Gross; Christopher M Heaphy; Yositaka Hosokawa; Edward Gabrielson; Alan K Meeker; Kala Visvanathan; Pedram Argani; Kurtis E Bachman; Ben Ho Park
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

4.  The butterfly effect in cancer: a single base mutation can remodel the cell.

Authors:  Jonathan R Hart; Yaoyang Zhang; Lujian Liao; Lynn Ueno; Lisa Du; Marloes Jonkers; John R Yates; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

Review 5.  Mutant p53: one name, many proteins.

Authors:  William A Freed-Pastor; Carol Prives
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

6.  Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells.

Authors:  H Park; M A Adams; P Lachat; F Bosman; S C Pang; C H Graham
Journal:  Biochem Biophys Res Commun       Date:  2000-09-16       Impact factor: 3.575

Review 7.  p53 mutations in cancer.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Nat Cell Biol       Date:  2013-01       Impact factor: 28.824

Review 8.  Losing balance: the origin and impact of aneuploidy in cancer.

Authors:  Andrew J Holland; Don W Cleveland
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

Review 9.  Gene copy-number alterations: a cost-benefit analysis.

Authors:  Yun-Chi Tang; Angelika Amon
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

Review 10.  Mutant p53 in cancer: new functions and therapeutic opportunities.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

View more
  11 in total

1.  PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity.

Authors:  Sarah Croessmann; Hong Yuen Wong; Daniel J Zabransky; David Chu; D Marc Rosen; Justin Cidado; Rory L Cochran; W Brian Dalton; Bracha Erlanger; Karen Cravero; Berry Button; Kelly Kyker-Snowman; Paula J Hurley; Josh Lauring; Ben Ho Park
Journal:  Breast Cancer Res Treat       Date:  2017-02-11       Impact factor: 4.872

2.  Mutational profiles of breast cancer metastases from a rapid autopsy series reveal multiple evolutionary trajectories.

Authors:  Bracha Erlanger Avigdor; Ashley Cimino-Mathews; Angelo M DeMarzo; Jessica L Hicks; James Shin; Saraswati Sukumar; John Fetting; Pedram Argani; Ben H Park; Sarah J Wheelan
Journal:  JCI Insight       Date:  2017-12-21

3.  Multifaceted and Intricate Oncogenic Mechanisms of NDRG1 in Head and Neck Cancer Depend on Its C-Terminal 3R-Motif.

Authors:  Guo-Rung You; Joseph T Chang; Hsiao-Fan Li; Ann-Joy Cheng
Journal:  Cells       Date:  2022-05-07       Impact factor: 7.666

Review 4.  Centrosome amplification: a suspect in breast cancer and racial disparities.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Endocr Relat Cancer       Date:  2017-05-17       Impact factor: 5.678

5.  Oncogenic MNK signalling regulates the metastasis suppressor NDRG1.

Authors:  Shuye Tian; Xuemin Wang; Christopher G Proud
Journal:  Oncotarget       Date:  2017-07-11

6.  N-myc downstream-regulated gene 1 promotes apoptosis in colorectal cancer via up-regulating death receptor 4.

Authors:  Xian Zhang; Bo Feng; Fan Zhu; Chaoran Yu; Jiaoyang Lu; Meng Pan; Zirui He; Xiongzhi Wangpu; Jing Sun; Xiao Yang
Journal:  Oncotarget       Date:  2017-07-28

7.  Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

8.  The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.

Authors:  Anup Sharma; Janet Mendonca; James Ying; Hea-Soo Kim; James E Verdone; Jelani C Zarif; Michael Carducci; Hans Hammers; Kenneth J Pienta; Sushant Kachhap
Journal:  Mol Oncol       Date:  2017-05-02       Impact factor: 6.603

9.  NDRG1 regulates neutral lipid metabolism in breast cancer cells.

Authors:  Christopher J Sevinsky; Faiza Khan; Leila Kokabee; Anza Darehshouri; Krishna Rao Maddipati; Douglas S Conklin
Journal:  Breast Cancer Res       Date:  2018-06-14       Impact factor: 6.466

Review 10.  Keep Calm and Carry on with Extra Centrosomes.

Authors:  Batuhan Mert Kalkan; Selahattin Can Ozcan; Nicholas J Quintyne; Samantha L Reed; Ceyda Acilan
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.